Financial Summary (All financials)
| In millions, except per share items | Mar-31-23 | Mar-05-23 | Mar-31-22 | Mar-05-22 | Mar-31-21 | Mar-31-20 | Mar-31-19 |
| Revenues | 299.5 | 299.5 | 271.9 | 271.9 | 243.9 | 305.5 | 440.9 |
| Revenue growth | 10.1% | 10.1% | 11.5% | | -20.1% | -30.7% | |
| Cost of goods sold | 165.0 | 165.0 | 138.9 | 138.9 | 126.9 | 168.0 | 248.0 |
| Gross profit | 134.5 | 134.5 | 132.9 | 132.9 | 117.0 | 137.4 | 192.9 |
| Gross margin | 44.9% | 44.9% | 48.9% | 48.9% | 48.0% | 45.0% | 43.7% |
| Sales and marketing | 119.9 | 119.9 | 100.3 | 100.3 | 43.2 | 110.5 | 190.8 |
| Research and development | 222.6 | 222.6 | 189.4 | 189.4 | 159.9 | 181.3 | 140.5 |
| General and administrative | 116.0 | 116.0 | 97.4 | 97.4 | 99.1 | 59.4 | 50.3 |
| EBITA | -306.7 | -324.0 | -246.6 | -254.2 | -185.2 | -213.8 | -188.8 |
| EBITA margin | -102.4% | -108.2% | -90.7% | -93.5% | -75.9% | -70.0% | -42.8% |
| Amortization of intangibles | 17.3 | | 7.6 | | | | |
| EBIT | -324.0 | -324.0 | -254.2 | -254.2 | -185.2 | -213.8 | -188.8 |
| EBIT margin | -108.2% | -108.2% | -93.5% | -93.5% | -75.9% | -70.0% | -42.8% |
| Pre-tax income | -314.4 | -314.4 | -221.0 | -221.0 | -183.6 | -250.9 | -183.5 |
| Income taxes | -2.8 | -2.8 | -3.5 | -3.5 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.9% | 0.9% | 1.6% | 1.6% | 0.0% | 0.0% | 0.0% |
| Net income | -311.7 | -311.7 | -217.5 | -217.5 | -183.6 | -250.9 | -183.5 |
| Net margin | -104.1% | -104.1% | -80.0% | -80.0% | -75.3% | -82.1% | -41.6% |
| |
| Diluted EPS | ($0.69) | | ($0.60) | | ($1.84) | ($2.84) | ($5.32) |
| Shares outstanding (diluted) | 451.5 | | 361.5 | | 99.7 | 88.2 | 34.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|